Fidelity in functional coupling of the rat P2Y(1) receptor to phospholipase C

被引:49
作者
Schachter, JB [1 ]
Boyer, JL [1 ]
Li, Q [1 ]
Nicholas, RA [1 ]
Harden, TK [1 ]
机构
[1] UNIV N CAROLINA,SCH MED,DEPT PHARMACOL,CHAPEL HILL,NC 27599
关键词
P2Y(1) receptor; purine nucleotide; signalling; inositol lipid signalling; cyclic AMP;
D O I
10.1038/sj.bjp.0701479
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The rat homologue of the P2Y1 receptor has been heterologously expressed in 1321N1 human astrocytoma cells and in C6 rat glioma cells. 2 As has been shown previously for the turkey and human P2Y(1) receptors, the rat P2Y(1) receptor expressed in either cell type responded to 2MeSATP with increases in inositol phosphate accumulation that were competitively blocked by the antagonist PPADS. Neither of the wild type cell lines exhibited inositol phosphate responses to P2Y(1) receptor agonists. 3 Expression of the rat P2Y(1) receptor did not confer a capacity of 2MeSATP to inhibit adenylyl cyclase activity in 1321N1 cells. Moreover, the inhibition of adenylyl cyclase mediated by an endogenous P2Y receptor of C6 glioma cells was not enhanced by expression of the rat P2Y(1) receptor. The P2Y receptormediated inhibition of adenylyl cyclase in C6 glioma cells expressing both the endogenous P2Y receptor and the rat P2Y(1) receptor remained unaffected by PPADS. 4 Since the P2Y receptor responsible for inhibition of adenylyl cyclase in C6 glioma cells does not share the pharmacological or functional properties of the PZY(1) receptor, even when both receptors originate from the same species and are simultaneously expressed in the same cell line, it is concluded that the P2Y(1) receptor is distinct from an endogenous P2Y receptor in C6 cells that couples to inhibition of adenylyl cyclase.
引用
收藏
页码:1021 / 1024
页数:4
相关论文
共 23 条
  • [1] CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES
    BERRIDGE, MJ
    DAWSON, RMC
    DOWNES, CP
    HESLOP, JP
    IRVINE, RF
    [J]. BIOCHEMICAL JOURNAL, 1983, 212 (02) : 473 - 482
  • [2] POTENT AGONIST ACTION OF 2-THIOETHER DERIVATIVES OF ADENINE-NUCLEOTIDES AT ADENYLYL CYCLASE-LINKED P-2Y-PURINOCEPTORS
    BOYER, JL
    OTUEL, JW
    FISCHER, B
    JACOBSON, KA
    HARDEN, TK
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (06) : 2611 - 2616
  • [3] BOYER JL, 1993, J PHARMACOL EXP THER, V267, P1140
  • [4] DIFFERENTIAL-EFFECTS OF P-2-PURINOCEPTOR ANTAGONISTS ON PHOSPHOLIPASE C-COUPLED AND ADENYLYL CYCLASE-COUPLED P-2Y-PURINOCEPTORS
    BOYER, JL
    ZOHN, IE
    JACOBSON, KA
    HARDEN, TK
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) : 614 - 620
  • [5] Boyer JL, 1996, MOL PHARMACOL, V50, P1323
  • [6] MOLECULAR-CLONING AND FUNCTIONAL-ANALYSIS OF A NOVEL P-2 NUCLEOTIDE RECEPTOR
    CHANG, KG
    HANAOKA, K
    KUMADA, M
    TAKUWA, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) : 26152 - 26158
  • [7] Cloning, functional expression and tissue distribution of the human P2Y(6) receptor
    Communi, D
    Parmentier, M
    Boeynaems, JM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 222 (02) : 303 - 308
  • [8] Cloning and functional expression of a human uridine nucleotide receptor
    Communi, D
    Pirotton, S
    Parmentier, M
    Boeynaems, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) : 30849 - 30852
  • [9] Comstock K E, 1997, Methods Mol Biol, V62, P207
  • [10] DUBYAK GR, 1993, AM J PHYSIOL, V265, pC557